Skip to main content

EQL · EQL Pharma AB · Financials

23.4000 SEK +0.7000 (+3.08%) At close · Oct 2
Market Cap
679.18M SEK
Shares
29.53M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
432.66M +15.8%
FY2026 Revenue FY2024–FY2026
Net Income
12.54M -70.9%
FY2026 Net Income FY2024–FY2026
Gross Margin
37.64% -4.1pp
FY2026 Gross Margin FY2024–FY2026
Operating Margin
11.25% -6.8pp
FY2026 Operating Margin FY2024–FY2026
Operating Cash Flow
28.36M +215%
FY2026 Operating Cash Flow FY2024–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024
SEK 432.66M 373.52M 264.17M
SEK 269.82M 217.56M 149.12M
SEK 162.84M 155.95M 115.05M
SEK 14.33M 11.26M 12.09M
SEK 22.48M 19.7M 21.83M
SEK 48.69M 67.37M 32.62M
SEK 30.49M 13.02M —
SEK 18.21M 54.35M 28.6M
SEK 5.67M 11.23M 5.9M
SEK 12.54M 43.12M 22.71M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current lease liabilities 2026-03-31 SEK 2,900,000 ESEF Annual Report filed 2026-07-24
Noncurrent bonds issued 2026-03-31 SEK 342,486,000 ESEF Annual Report filed 2026-07-24
Noncurrent lease liabilities 2026-03-31 SEK 2,687,000 ESEF Annual Report filed 2026-07-24
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.